BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17435772)

  • 1. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.
    Sakuma R; Noser JA; Ohmine S; Ikeda Y
    Nat Med; 2007 May; 13(5):631-5. PubMed ID: 17435772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.
    Sakuma R; Ohmine S; Ikeda Y
    J Biol Chem; 2010 Feb; 285(6):3784-3793. PubMed ID: 19951947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J
    Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.
    Sakuma R; Noser JA; Ohmine S; Ikeda Y
    Gene Ther; 2007 Jan; 14(2):185-9. PubMed ID: 16943852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
    PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
    Javanbakht H; Diaz-Griffero F; Stremlau M; Si Z; Sodroski J
    J Biol Chem; 2005 Jul; 280(29):26933-40. PubMed ID: 15897199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection.
    Kono K; Song H; Shingai Y; Shioda T; Nakayama EE
    Virology; 2008 Apr; 373(2):447-56. PubMed ID: 18201746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1.
    Pan Q; Rong L; Zhao X; Liang C
    Virology; 2009 Apr; 387(1):127-35. PubMed ID: 19249802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity.
    Kono K; Bozek K; Domingues FS; Shioda T; Nakayama EE
    Virology; 2009 May; 388(1):160-8. PubMed ID: 19342071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.
    Diaz-Griffero F; Vandegraaff N; Li Y; McGee-Estrada K; Stremlau M; Welikala S; Si Z; Engelman A; Sodroski J
    Virology; 2006 Aug; 351(2):404-19. PubMed ID: 16650449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.
    Nakayama EE; Maegawa H; Shioda T
    Virology; 2006 Jun; 350(1):158-63. PubMed ID: 16647098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.
    Zhang J; Ge W; Zhan P; De Clercq E; Liu X
    Curr Med Chem; 2011; 18(17):2649-54. PubMed ID: 21568899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells.
    Nakayama EE; Shingai Y; Kono K; Shioda T
    Virology; 2008 Jun; 375(2):514-20. PubMed ID: 18367226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human immunodeficiency virus type 1 Gag ubiquitination.
    Gottwein E; Kräusslich HG
    J Virol; 2005 Jul; 79(14):9134-44. PubMed ID: 15994808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection.
    Liu HL; Wang YQ; Liao CH; Kuang YQ; Zheng YT; Su B
    Gene; 2005 Dec; 362():109-16. PubMed ID: 16226405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of human TRIM5alpha on HIV-1 production.
    Zhang X; Kondo M; Chen J; Miyoshi H; Suzuki H; Ohashi T; Shida H
    Microbes Infect; 2010 Sep; 12(10):768-77. PubMed ID: 20493962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.